Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-043855
Filing Date
2017-07-05
Accepted
2017-07-05 21:34:54
Documents
1
Period of Report
2017-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3764
  Complete submission text file 0001209191-17-043855.txt   5095
Mailing Address 3338 LANCASHIRE RD FURLONG PA 18925
Business Address
Rowland Charles A Jr (Reporting) CIK: 0001383292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 17950737

Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations